COVID-19: First Trial of Oxford University’s Vaccine Shows Promising Immune Response
News | Jul 21, 2020, 08:12 AM ISTThe experimental coronavirus vaccine developed by AstraZeneca in collaboration with Oxford University has shown promising results and produced an immune response in part one of the two-phase clinical trials, a data was released on Monday.